Massimiliano Gennaro
Milan, MI, 20133, Italy
NCT Number: NCT03002766
By this non-randomized prospective study, it's evaluated the outcome of patients underwent BCS for DCIS at whom an established score system to address adjuvant therapies have been prospectively applied, according to the wideness of free margins.
Between March 2000 and April 2006, 224 patients were enrolled and followed within the study.
Looking for future studies?
Notify Me18 year and older
Female
Interventional
Phase 2
Milan, MI, 20133, Italy
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: six years
Time frame: six years
the side effects of radiotherapy may outweigh the reduction in the risk of IBTR
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Other
Ten Years Results of a Score System to Address Adjuvant Therapies After Breast Conserving Surgery for Ductal Carcinoma in Situ of the Breast.
Acronym: DCIS
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05461430
Adenocarcinoma, Adenoma
Oakland, California, United States
View Trial DetailsNCT03113825
Adenocarcinoma, Breast Cancer Female
San Diego, California, United States
View Trial DetailsNCT01849133
Breast Diseases, Breast Neoplasms
Milan, Italy
View Trial DetailsNCT03768492
Breast Diseases, Breast Neoplasms
New York, United States
View Trial Details